Get (NYE | ABBV AbbVie Inc) latest stock price, analyst ratings, fundamental analysis, ratios, market performance, news, target price and financial report

Find the latest AbbVie Inc. (ABBV) stock quote, history, news and other vital information to help you with your stock trading and investing.

The one-year ABBV stock forecast points to a potential upside of 12.22. The average equity rating for ABBV stock is currently 2.00, trading closer to a bullish pattern in the stock market. The all-time high AbbVie stock closing price was 123.21 on January 26, 2018 . The AbbVie 52-week high stock price is 113.41 , which is 5.5% above the current share price. The AbbVie 52-week low stock price is 78.66 , which is 26.9% below the current share price. The average AbbVie stock price for the last 52 weeks is 96.99 .

Abbv stock price

Abbvie Inc quote is equal to 106.230 USD at 2021-04-09. Based on our forecasts, a long-term increase is expected, the "ABBV" stock price prognosis for 2026-04-03 is 200.439 USD. ABBV STOCK PRICE TODAY; Last Close: 107.54: Previous Close: 106.10: Change: 1.44 % Change: 1.36%: Last High: 107.72: Last Low: 106.05: Volume: 5,955,929: Market Cap Stable Share Price: ABBV is less volatile than 75% of US stocks over the past 3 months, typically moving +/- 4% a week. Volatility Over Time : ABBV's weekly volatility (4%) has been stable over the past year. 2020-07-21 · Despite over a 55% rise since the March 23 lows of this year, at the current price of around $100 per share we believe AbbVie stock has more room for growth.

2021-03-26 · AbbVie Inc. [NYSE: ABBV] slipped around -1.78 points on Wednesday, while shares priced at $103.06 at the close of the session, down -1.70%. The company report on March 22, 2021 that SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of AbbVie Inc. – ABBV. Get the

Find real-time ABBV - Abbvie Inc stock quotes, company profile, news and forecasts from CNN Business. 2020-08-19 · View the latest AbbVie Inc. (ABBV) stock price, news, historical charts, analyst ratings and financial information from WSJ. AbbVie's stock was trading at $84.85 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, ABBV shares have increased by 27.2% and is now trading at $107.91.

2020-12-02

The company report on March 22, 2021 that SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of AbbVie Inc. – ABBV. Get the ABBV's equity multiplier -- a measure of assets relative to shareholders'equity -- is greater than that of 96.66% of US stocks.

AbbVie (ABBV) Stock Sinks As Market Gains: What You Should Know - April 13, 2021 - Zacks.com 2020-11-25 · According to studies, the price of Humira has more than tripled since 2006, with one-year supply prices rising from $16,636 to $72,000 currently. 2020-08-19 · View the latest AbbVie Inc. (ABBV) stock price, news, historical charts, analyst ratings and financial information from WSJ. 2021-04-09 · AbbVie (ABBV) Outpaces Stock Market Gains: What You Should Know AbbVie (ABBV) closed at $110.26 in the latest trading session, marking a +1.89% move from the prior day. 3 weeks ago - Zacks Investment Research Their average twelve-month price target is $115.75, suggesting a possible upside of 9.4%. SVB Leerink LLC has the highest price target set, predicting ABBV will reach $144.00 in the next twelve months.
Hur lägga hårda spår

October Assuming the SEK 33.50 per share price announced in. Correction of Underlying Equity Prices applies. Correction 9 ABBVIE INC. (ABBV UN). No. ABBVIE INC. NEW YORK.

ABBV · AbbVie, 104.47, -0.91, -0.86%, 32.98%, 2021-04-07. ABT · Abbott, 119.96, 0.04, 0.03%, 41.21%, 2021-04-07.
Sweden internship visa

depeche mode historia da banda
helsa vardcentral sundbyberg
leif haraldsson grums
sintra centrum
rostfria bultar biltema
teknik gymnasiearbete ideer
max skellefteå jobb

Få detaljerad information om Excel Price Feed, dess användbarhet, data for a variety of financial products including stocks, stock indices, commodities,

The deal closed in May 2020. In June 2016, AbbVie acquired cancer drugmaker, Stemcentrx in a cash-and Shares Value. Mar 1, 2021 Sale. Richard A. Gonzalez Chairman of the Board and CEO; Director. Disposition $109.32 PER SHARE. -631 $-68,981. Mar 1, 2021 Sale.